Market Cap 191.07M
Revenue (ttm) 57.80M
Net Income (ttm) -97.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -169.45%
Debt to Equity Ratio 0.00
Volume 4,322,100
Avg Vol 4,992,576
Day's Range N/A - N/A
Shares Out 301.71M
Stochastic %K 20%
Beta 1.22
Analysts Strong Sell
Price Target $4.10

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 970 6000
Address:
501 Canal Blvd, Richmond, United States
JimiJoJeeter
JimiJoJeeter Oct. 27 at 3:13 PM
$SGMO Hmmmmm.... the extension was probably requested!
0 · Reply
biotech
biotech Oct. 27 at 3:01 PM
$SGMO shorts covering 1.7M shares
0 · Reply
JimiJoJeeter
JimiJoJeeter Oct. 27 at 2:53 PM
$SGMO Looks like the jury is in early. I'm seeing a dair amount of red. Looks like the market is still oblivious to the differences between crspr and zfn editing, regulation, and therapy. Great time for a statrment about it ftom MacFuckFace. Oh wait, he's too busy polishing his fangs, preparing to suck more money out of shareholders!
1 · Reply
SilentSniper
SilentSniper Oct. 27 at 2:20 PM
$SGMO Sangamo and its safe Zinc Finger tech stand to benefit with the downfall of CRSPR
3 · Reply
Badrabitt
Badrabitt Oct. 27 at 2:00 PM
$SGMO Looks like were going back down first floor
0 · Reply
Prittykitty
Prittykitty Oct. 27 at 1:25 PM
$SGMO everyone already knew crispr products are wild cards. Lets get this buyout done already.
0 · Reply
JimiJoJeeter
JimiJoJeeter Oct. 27 at 1:24 PM
$SGMO Will NTLA drag all biotech down with it? Anyone care to guess?
2 · Reply
Top_Dog_Pro_Trader
Top_Dog_Pro_Trader Oct. 27 at 12:42 PM
$SGMO looks like CRSP’s gene editing has some major issues. SGMO’s perhaps largest competitor maybe toast…IMO!
1 · Reply
Moveme1mm
Moveme1mm Oct. 27 at 12:40 PM
0 · Reply
GothamGirl
GothamGirl Oct. 27 at 12:23 PM
$SGMO NTLA down 46% premarket on liver issues. Will this be good or bad news for SGMO?
1 · Reply
Latest News on SGMO
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call

Jul 31, 2025, 4:05 PM EDT - 3 months ago

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call


Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

May 6, 2025, 4:35 PM EDT - 6 months ago

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call


Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet

Dec 31, 2024, 12:01 PM EST - 10 months ago

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet


JimiJoJeeter
JimiJoJeeter Oct. 27 at 3:13 PM
$SGMO Hmmmmm.... the extension was probably requested!
0 · Reply
biotech
biotech Oct. 27 at 3:01 PM
$SGMO shorts covering 1.7M shares
0 · Reply
JimiJoJeeter
JimiJoJeeter Oct. 27 at 2:53 PM
$SGMO Looks like the jury is in early. I'm seeing a dair amount of red. Looks like the market is still oblivious to the differences between crspr and zfn editing, regulation, and therapy. Great time for a statrment about it ftom MacFuckFace. Oh wait, he's too busy polishing his fangs, preparing to suck more money out of shareholders!
1 · Reply
SilentSniper
SilentSniper Oct. 27 at 2:20 PM
$SGMO Sangamo and its safe Zinc Finger tech stand to benefit with the downfall of CRSPR
3 · Reply
Badrabitt
Badrabitt Oct. 27 at 2:00 PM
$SGMO Looks like were going back down first floor
0 · Reply
Prittykitty
Prittykitty Oct. 27 at 1:25 PM
$SGMO everyone already knew crispr products are wild cards. Lets get this buyout done already.
0 · Reply
JimiJoJeeter
JimiJoJeeter Oct. 27 at 1:24 PM
$SGMO Will NTLA drag all biotech down with it? Anyone care to guess?
2 · Reply
Top_Dog_Pro_Trader
Top_Dog_Pro_Trader Oct. 27 at 12:42 PM
$SGMO looks like CRSP’s gene editing has some major issues. SGMO’s perhaps largest competitor maybe toast…IMO!
1 · Reply
Moveme1mm
Moveme1mm Oct. 27 at 12:40 PM
0 · Reply
GothamGirl
GothamGirl Oct. 27 at 12:23 PM
$SGMO NTLA down 46% premarket on liver issues. Will this be good or bad news for SGMO?
1 · Reply
biotech
biotech Oct. 27 at 11:47 AM
$SGMO NON CRISPR GENE EDITING re $NTLA news crashing $CRSP and crispr dirt stocks Sangamo only perfect safe gene editor not using this crispr killer stuff
0 · Reply
MAKO1992
MAKO1992 Oct. 27 at 11:07 AM
$SGMO Takeda and Astellas earnings reports this Thursday... maybe we are waiting for this
2 · Reply
Ali100_A
Ali100_A Oct. 27 at 11:01 AM
$SGMO Sandy, when will you pull your fingers out of your backside and do something like this: https://www.fiercebiotech.com/biotech/novartis-goes-big-neuroscience-12b-deal-late-stage-dystrophy-biotech-avidity
0 · Reply
TwoThirdsProbablyDown
TwoThirdsProbablyDown Oct. 27 at 10:38 AM
$SGMO silence is good because it means negotiations might be in the works. Press releases about nothing are what you need to be afraid of.
0 · Reply
TwoThirdsProbablyDown
TwoThirdsProbablyDown Oct. 27 at 10:37 AM
$SGMO is this the week?
0 · Reply
BuyThisOne
BuyThisOne Oct. 27 at 10:16 AM
$SGMO Am I going to lose 80k here or get richer? It is hard to have any feelings here right now. I have hope but damn the silence is deafening.
0 · Reply
Stueytothemoon
Stueytothemoon Oct. 26 at 7:32 PM
$SGMO there is not only one form 4 that has been filed. There are multiple on the investors page!! Take a look and share your opinions of what that means?
4 · Reply
Ride2Abide
Ride2Abide Oct. 26 at 7:24 PM
$SGMO 12 Billion rare disease Co. buyout is nice to see: Swiss pharmaceutical giant Novartis $NVS announced Sunday it had agreed to buy Avidity Biosciences, with the San Diego-based biopharmaceutical company being valued at $12 billion.
0 · Reply
Ihuarraqax123
Ihuarraqax123 Oct. 26 at 2:47 PM
$SGMO tomorrow delisting, rubish stock. Over 10k usd lost.
3 · Reply
Sloppyb
Sloppyb Oct. 26 at 2:43 PM
$SGMO @Futurision how are you feeling about our odds this week?
2 · Reply
809trader
809trader Oct. 25 at 10:45 PM
$SGMO I’m gonna leave this here.
0 · Reply
Swamp_Yankee
Swamp_Yankee Oct. 25 at 9:25 PM
$SGMO I'm gonna buy all of razzledazzles shares when he folds this week. And he will fold.
1 · Reply